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Background: Diesel exhaust particles (DEP) contribute substantially to ambient particulate matter (PM) air pollution
in urban areas. Inhalation of PM has been associated with increased incidence of lung disease in susceptible
populations. We have demonstrated that the glutathione S-transferase M1 (GSTM1) null genotype could aggravate
DEP-induced airway inflammation in human subjects. Given the critical role airway epithelial cells play in the
pathogenesis of airway inflammation, we established the GSTM1 deficiency condition in primary bronchial epithelial
cells from human volunteers with GSTM1 sufficient genotype (GSTM1+) using GSTM1 shRNA to determine whether
GSTM1 deficiency could exaggerate DEP-induced expression of interleukin-8 (IL-8) and IL-1β proteins. Furthermore,
the mechanisms underlying GSTM1 regulation of DEP-induced IL-8 and IL-1β expression were also investigated.
Methods: IL-8 and IL-1β protein levels were measured using enzyme-linked immunosorbent assay. GSTM1
deficiency in primary human bronchial epithelial cells was achieved using lentiviral GSTM1 shRNA particles and
verified using real-time polymerase chain reaction and immunoblotting. Intracellular reactive oxygen species (ROS)
production was evaluated using flow cytometry. Phosphorylation of protein kinases was detected using
immunoblotting.
Results: Exposure of primary human bronchial epithelial cells (GSTM1+) to 25-100 μg/ml DEP for 24 h significantly
increased IL-8 and IL-1β protein expression. Knockdown of GSTM1 in these cells further elevated DEP-induced IL-8
and IL-1β expression, implying that GSTM1 deficiency aggravated DEP-induced pro-inflammatory response. DEP
stimulation induced the phosphorylation of extracellular signal-regulated kinase (ERK) and Akt, the downstream
kinase of phosphoinositide 3-kinase (PI3K), in GSTM1+ bronchial epithelial cells. Pharmacological inhibition of ERK
kinase and PI3K activity blocked DEP-induced IL-8 and IL-1β expression. DEP-induced ERK and Akt phosphorylation
could be increased by GSTM1 knockdown. In addition, pretreatment of HBEC with the antioxidant N-acetyl cysteine
significantly inhibited DEP-induced ERK and Akt phosphorylation, and subsequent IL-8 and IL-1β expression.
Conclusion: GSTM1 regulates DEP-induced IL-8 and IL-1β expression in primary human bronchial epithelial cells by
modulation of ROS, ERK and Akt signaling.
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Diesel exhaust particles (DEP) emitted during the com-
bustion of diesel fuel are an important contributor to
the levels of particulate matter (PM) air pollution in
urban areas. These particles comprise a carbonaceous
core to which organic and inorganic compounds, such
as polycyclic aromatic hydrocarbons (PAHs), nitro and
oxygenated derivatives of PAHs, heterocyclic com-
pounds, aldehydes, aliphatic hydrocarbons, and heavy
metals, can be adsorbed. Epidemiological and experi-
mental studies have shown that DEP inhalation is asso-
ciated with elevated incidence of diverse respiratory
disorders including pulmonary inflammation, increased
susceptibility to respiratory infections, increased risk of
lung cancer, and exacerbation of asthma and chronic
obstructive pulmonary diseases [1-4]. However, the
mechanisms underlying DEP-induced pulmonary disor-
ders have not yet been adequately elucidated.
The pathogenesis of many respiratory diseases is charac-
terized by airway inflammation, which is driven by a pleth-
ora of pro-inflammatory mediators released from airway
resident and infiltrating inflammatory cells [5]. The airway
epithelium represents the interface between the external
environment and the tissue of the airway wall [6]. The
production of pro-inflammatory mediators from airway
epithelium plays a critical role in the pathogenesis of pul-
monary diseases [5,7]. Exposure to air pollution particles
has been shown to evoke pro-inflammatory mediator pro-
duction in airway epithelial cells [8-10]. It has been
demonstrated that the pro-inflammatory effect of air par-
ticles is affected by many factors, such as particle size,
concentration, composition, duration of exposure, and co-
pollutants [11]. Increasing evidence indicates that the host
susceptibility factors may also play an important role in
air pollutant-induced lung inflammation [12,13]. Suscepti-
bility to the adverse effects of air pollutants is an intrinsic
trait most probably related to genotypes [14]. Animal
studies have shown that prolonged low-dose DEP ex-
posure induces airway inflammatory responses that differ
remarkably among mouse strains with different genetic
backgrounds of oxidative stress response [15]. It has
been proposed that host responses to DEP are regu-
lated by a balance between antioxidant defenses and
pro-inflammatory responses [16]. The lung has multiple
anti-oxidative defense systems including the glutathione
S-transferases (GSTs) [17]. The GSTs are a supergene
family of phase II conjugating enzymes that consist of
a number of sub-classes such as GSTM1 and GSTP1,
and catalyze the conjugation of reduced glutathione
with hydrophobic electrophiles and reactive oxygen spe-
cies (ROS) [18]. GSTM1 is mapped to the GST mu 1
gene cluster on chromosome 1p13.3. Genetic variants
that regulate the availability and functionality of the
GST enzymes determine the levels of oxidative effectsin the airway and associated injury [19]. GST gene poly-
morphisms, particularly the GSTM1 null genotype, are
frequent in the population with reported frequencies
from 18 to 66% in different ethnic groups [20]. The de-
letion variants or null alleles that exist for the GSTM1
gene present biochemically as a failure to express pro-
tein [21,22]. Individuals with the GSTM1 null genotype
completely lack the GSTM1 enzyme activity and their
susceptibility to asthma and lower lung function is
increased [23-25].
Our previous studies have demonstrated that the
GSTM1 null genotype is associated with aggravation of
airway inflammation in human subjects exposed to di-
verse air toxicants including ozone, endotoxin, DEP, and
second hand smoke [14,26-28], implying that GSTM1
deficiency might be a risk factor in air pollutant-induced
lung diseases. It should be noted that these in vivo stud-
ies investigated only the association of GSTM1 genotype
with pollutant-induced lung inflammation, and they can-
not exclude the contribution of other genetic factors in
the modulation of response to air pollutants. To our
knowledge, no mechanistic studies have been conducted
to examine the function of GSTM1 protein in the patho-
genesis of airway inflammation. Given the critical role
airway epithelial cells play in the pathogenesis of airway
inflammation, we manipulated GSTM1 levels in primary
human bronchial epithelial cells (HBEC) from human
volunteers with GSTM1 sufficient (GSTM1+) genotype
using GSTM1 shRNA to determine whether GSTM1 de-
ficiency could modulate DEP-induced pro-inflammatory
response, herein, the over-expression of interleukin-8
(IL-8) and IL-1β proteins. In addition, the mechanisms
whereby GSTM1 regulated DEP-induced IL-8 and IL-1β
protein expression were also examined.
Results and discussion
DEP exposure increases IL-8 and IL-1β protein expression
in GSTM1+ primary human bronchial epithelial cells
IL-8 is a major mediator of acute pulmonary inflamma-
tion as a chemoattractant for neutrophils [29,30]. IL-1β
is also an important mediator of the inflammatory re-
sponse that can also induce production of other pro-
inflammatory cytokines and chemokines [31]. Increased
levels of IL-8 and IL-1β have been observed in inflamma-
tory lung diseases [32,33]. In this study we used IL-8 and
IL-1β as the biomarker of pro-inflammatory response of
airway epithelial cells to DEP stimulation. Exposure of
HBEC to 100 μg/ml DEP for up to 24 h did not result in
significant alterations in cell viability, as assessed by assay
of lactate dehydrogenase activity released into the culture
medium. As shown in Figure 1A, exposure of HBEC to
25-100 μg/ml DEP for 24 h induced a significant increase
in IL-8 protein expression (F = 92.36, p < 0.01). Similarly,
DEP stimulation also induced a dose-dependent increase
Figure 1 DEP exposure increases IL-8 and IL-1β protein
expression in HBEC. Confluent HBEC were exposed to control (PBS)
or 25–100 μg/ml DEP for 24 h, respectively. IL-8 and IL-1β levels in
the supernatants of culture media were measured using ELISA.
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F = 46.22, P < 0.01). These results indicate that DEP
stimulation up-regulates IL-8 and IL-1β protein expres-
sion in GSTM1+ primary human bronchial epithelial
cells.
In regard to the environmental relevance of the DEP
concentration used in this study, a recent study has cal-
culated that a plausible real-world exposure could result
in an inhalational exposure of 0.9 mg of DEP in certain
settings such as bus depots, garages and tunnels [34].
With an approximately 5% deposition throughout the
conducting airways in a periciliary volume of 50-500 μl
this amount of DEP would result in a concentration be-
tween 90 and 900 μg/ml. Therefore, the DEP doses used
in this study (25-100 μg/ml) are relevant to real environ-
mental exposure situations.
The DEP used in this study was suspended in
molecular-grade water. It has been reported that these
DEP contain both redox metals and redox active organic
substances [35]. The metals appear to be tightly bound
to particles and are not extractable into water. To define
the contribution of metallic component to DEP-induced
biological effect, normal human bronchial epithelial cells
were pretreated with 100 μM deferoxamine for 2 h priorto 50 μg/ml DEP stimulation. It was shown that deferox-
amine had little inhibitory effect on DEP-induced ROS
production, ERK activation, as well as IL-8 expression
(data not shown). The particles also contain electro-
philes which exhibit both water and dichloromethane
solubility. To determine the contribution of aqueous ex-
tract to DEP-induced IL-8 expression in HBEC, we cen-
trifuged the DEP suspension at 13000 rpm for 30 min
and determined the effect of the supernatant of DEP
suspension on IL-8 expression in HBEC. It was found
that there was no significant difference in IL-8 induction
between DEP aqueous extract and control (data not
shown). This suggested that water soluble components
of DEP played a minimal role in DEP-induced pro-
inflammatory response.
GSTM1 knockdown significantly increases DEP-induced
IL-8 and IL-1β protein expression in HBEC
We have demonstrated that GSTM1 null genotype is
associated with aggravation of DEP-induced airway in-
flammation in human subjects. Given that the airway
epithelium plays an important role in regulating pul-
monary inflammatory responses and GSTM1 expression
has been detected in human airway cells [36], we
assumed that modulation of GSTM1 expression levels in
airway epithelial cells might affect DEP-induced IL-8
and IL-1β expression. To test this assumption, we estab-
lished the GSTM1 deficiency condition in vitro in HBEC
(GSTM1+) using lentiviral GSTM1 shRNA particles and
determined its effect on DEP-induced IL-8 and IL-1β
expression. This in vitro approach provided the oppor-
tunity of examining the contribution of GSTM1 defi-
ciency to DEP-induced pro-inflammatory response.
HBEC (GSTM1+) were infected with lentiviral
scrambled or GSTM1 shRNA particles, respectively,
prior to DEP treatment. As shown in Figure 2A and
B, infection of HBEC (GSTM1+) with 10 moi of lenti-
viral GSTM1 shRNA particles caused significant reduc-
tion of GSTM1 mRNA levels (by 77%) as well as
GSTM1 protein as compared to the cells infected with
lentiviral scrambled shRNA particles. Then, GSTM1
sufficient or knockdown cells were treated with PBS
control or 50 μg/ml DEP for 24 h. Levels of IL-8 and
IL-1β proteins in the supernatant of culture medium
were measured with ELISA and expressed as fold over
control. As expected, DEP stimulation increased IL-8
expression in HBEC infected with control (scrambled)
shRNA particles (Figure 2B). By comparison, DEP-
induced IL-8 production was further enhanced in the
cells infected with lentiviral GSTM1 shRNA particles
(Figure 2B). Similarly, knockdown of GSTM1 also
increased DEP-induced IL-1β expression (Figure 2C).
Taken together, these results indicated that GSTM1 de-
ficiency increased DEP-induced IL-8 and IL-1β
Figure 2 GSTM1 knockdown enhanced DEP-induced IL-8 and
IL-1β expression in HBEC. A and B, HBEC were infected with
lentiviral scrambled or GSTM1 shRNA particles (10 moi) for 24 h,
respectively. The cells were lysed for GSTM1 mRNA measurement
using RT-PCR (*P< 0.01)or GSTM1 protein determination using
immunoblotting. Infected HBEC with lentiviral scrambled or GSTM1
shRNA particles were treated with PBS control or 50 μg/ml DEP for
24 h. Levels of IL-8 (C) and IL-1β (D) proteins in the supernatant of
culture media were determined using ELISA and expressed as fold
over control (DEP vs. PBS control in scrambled or GSTM1 shRNA
group, respectively). *P< 0.05, compared to DEP treatment in the
scrambled shRNA group.
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in vivo observation that linked GSTM1 null genotype
to aggravation of DEP-induced airway inflammation.
The results that we present on the effect of shRNA-
mediated knockdown of GSTM1 on the expression of
the inflammatory proteins were compared to their re-
spective controls because inter-experiment variability in
the response of the cells is substantial. There are mul-
tiple factors that contribute to this variability, starting
with the fact that this study was conducted on primary
cultures of human airway epithelial cells, derived from
several donor subjects, over a period of many months.
Genetics, age of the culture, passage numbers, state of
activation of the cells, etc. are all known to contribute
significantly as determinants of the magnitude of the re-
sponse of these cells to stimulation.The ERK and PI3K/Akt signaling pathways regulate
DEP-induced IL-8 and IL-1β expression in HBEC
The inflammatory responses initiated by diverse external
stimulatory signals are usually regulated by activated
intracellular kinases in responsive cells [37]. The rapid
amplification of the initiating signal is correlated with a
number of downstream protein kinases. Protein kinases
have been shown to play a crucial role in the regulation
of inflammatory mediator expression in the airways [38].
Previous studies have shown that the involvement of
mitogen-activated protein kinases (MAPKs), including
extracellular signal-regulated kinase (ERK), c-Jun NH2-
terminal kinase (JNK), and p38 kinase pathways, and the
PI3K/Akt signaling cascade, in DEP-induced up-regula-
tion of inflammatory mediator genes is cell type-specific,
and also varies greatly with pro-inflammatory mediators
examined. For example, Takizawa et al. showed that
DEPs increased intracellular adhesion molecule-1 ex-
pression through p38, but not ERK, in the transformed
human bronchial epithelial cell line BEAS-2B [39]. In
contrast, Boland et al. demonstrated that DEP stimu-
lated granulocyte-macrophage colony-stimulating factor
production mainly through ERK, and to a lesser extent,
through p38 in another human bronchial epithelial cell
Figure 3 The ERK and the PI3K/Akt pathways are involved in
DEP-induced IL-8 and IL-1β expression. A, Confluent HBEC were
exposed to 50 μg/ml DEP for 1-4 h. Supernatants of cell lysates were
subjected to SDS–PAGE and immunoblotting using phospho- and
pan antibodies against ERK. B, HBEC were pretreated with vehicle
(DMSO), or 20 μM ERK kinase inhibitor U0126, for 30 min prior to
50 μg/ml DEP stimulation for 24 h, respectively. Levels of IL-8 and
IL-1β proteins were determined using ELISA and expressed as fold
over control. *P< 0.05, compared to DEP treatment in the vehicle
(DMSO) group. C, Confluent HBEC were exposed to 50 μg/ml DEP
for 1-4 h. Phosphorylated Akt was determined using
immunoblotting and phospho-specific antibody against Akt. D,
HBEC were pretreated with vehicle (DMSO), or 1 μM PI3K inhibitor
Wortmannin, for 30 min prior to 50 μg/ml DEP stimulation for 24 h,
respectively. Levels of IL-8 and IL-1β proteins were measured using
ELISA and expressed as fold over control (DEP vs. PBS control in
vehicle DMSO or inhibitor group, respectively). * P< 0.05, compared
to DEP treatment in the vehicle (DMSO) group.
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extracts could activate JNK in a human macrophage cell
line THP-1[41]. In a mouse epidermal cell line DEP ex-
posure modestly activated JNK, but had little effect on
ERK and p38 [42]. In this study, we examined whether
these protein kinases are involved in DEP-induced IL-8
and IL-1β expression in primary human bronchial epi-
thelial cells. Phosphorylation of MAPKs was measured
using phospho-specific antibodies against JNK, p38, and
ERK, respectively. As shown in Figure 3A, exposure of
HBEC to 50 μg/ml DEP induced a marked phosphoryl-
ation of ERK, but not p38 or JNK (data not shown),
which peaked at 1 h of exposure. To further determine
the role of ERK pathway in DEP-induced IL-8 and IL-1β
production, we used the specific inhibitor of the ERK
kinase U0126 to pretreat cells prior to DEP stimulation.
HBEC were pre-incubated with 20 μM U0126 for
30 min prior to treatment with 50 μg/ml DEP for 24 h.
IL-8 and IL-1β protein levels were measured with
ELISA. As shown in Figure 3B, pretreatment of HBEC
with U0126 significantly blocked DEP-induced IL-8 and
IL-1β expression, indicating that the ERK signaling path-
way was involved in DEP-induced IL-8 and IL-1β
expression.
Next, we examined the involvement of the PI3K/Akt
signaling pathway in DEP-induced IL-8 and IL-1β ex-
pression in DEP-treated HBEC. Activation of the PI3K/
Akt signaling was determined by measuring the phos-
phorylation of Akt [43]. As demonstrated in Figure 3C,
DEP stimulation (50 μg/ml) induced an acute and sus-
tained Akt phosphorylation, indicating that the PI3K/
Akt pathway was activated by DEP stimulation. To fur-
ther determine whether this pathway was involved in
DEP-induced IL-8 and IL-1β expression, wortmannin,
the selective inhibitor of the PI3K, was used to pretreat
HBEC. HBEC were pretreated with 1 μM wortmannin
for 30 min before further treatment with 50 μg/ml DEP
for 24 h. As shown in Figure 3D, wortmannin pretreat-
ment inhibited DEP-induced IL-8 and IL-1β expression.
These results showed that the PI3K/Akt signaling path-
way is activated by DEP stimulation, further up-
regulating IL-8 and IL-1β expression.
It has been proposed that the expression of inflamma-
tory genes can be regulated at both transcriptional and
posttranscriptional levels [44,45]. Exactly how the ERK
and PI3K/Akt signaling pathways up-regulate DEP-
induced IL-8 and IL-1β expression remains to be defined.
Knockdown of GSTM1 further increases DEP-induced ERK
and Akt activities
The possible mechanisms underlying GSTM1-modulated
lung inflammation are largely unknown. GSTM1 detoxi-
fies electrophilic compounds by catalyzing their conjuga-
tion with reduced GSH. It is presumed that intermediateelectrophilic metabolites, arising in the first phase of de-
toxification, are not metabolized in GSTM1-null asthma
patients and are not excreted. These intermediate meta-
bolites may damage cells and generate oxidative stress,
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[46]. In addition to this well-characterized catalytic activ-
ity, recent evidence has suggested that GSTM1 may con-
trol oxidative stress and inflammation through the
regulation of intracellular signaling pathways by its effects
on certain small molecules or by protein-protein interac-
tions with critical kinases. The ligand-binding capacity of
GSTM1 results in the negative regulation of signaling
pathways through sequestration of signaling kinases [47].
As demonstrated previously, GSTM1, ERK and Akt
were all involved in the regulation of DEP-induced IL-8
and IL-1β expression in HBEC. We hypothesized that
enhancement of DEP-induced IL-8 and IL-1β protein
expression by GSTM1 deficiency might be achieved
through modulation of ERK and Akt activities. To test
this hypothesis, we reduced GSTM1 expression levels in
HBEC with GSTM1 shRNA and examined ERK and Akt
phosphorylation induced by DEP exposure. HBEC with
sufficient or deficient GSTM1 were treated with 50 μg/ml
DEP for 1 h. Phosphorylation of ERK and Akt was deter-
mined using immunoblotting, respectively. In the cells
expressing sufficient GSTM1 DEP stimulation increased
both ERK and Akt phosphorylation (Figure 4A and B). InFigure 4 GSTM1 knockdown enhances DEP-induced ERK and
Akt activation. HBEC were infected with lentiviral scrambled or
GSTM1 shRNA particles (10 moi) for 24 h, respectively. Confluent cells
were treated with PBS control (Ct) or 50 μg/ml DEP for 1 h. The
supernatants of the cell lysates were subjected to immunoblotting
using phospho- or pan antibodies against ERK (A) or Akt (B),
respectively. Shown are representative bands derived from 4
separate experiments. Nos. are mean relative optical densities of
phorspho-proteins compared to control.contrast, in the cells with reduced GSTM1 expression the
phosphorylation levels of ERK and Akt induced by DEP
exposure were modestly enhanced, indicating that GSTM1
deficiency could promote DEP-induced ERK and Akt
activation.
The mechanisms whereby GSTM1 deficiency modu-
lated DEP-induced ERK and PI3K/Akt activation were
under speculation. Given the oxidative property of many
air pollutants and the feature of ROS as the second mes-
senger in intracellular signaling network [48,49], we
envisioned that the anti-oxidant GSTM1 might affect
ERK and Akt activity through modulation of intracellu-
lar ROS production in HBEC exposed to DEP. The two
main organic compounds adsorbed on DEP, PAHs and
quinones, have been demonstrated to contribute to ROS
production through enzymatic or non-enzymatic reac-
tions [41,50-54]. DEP-induced intracellular ROS produc-
tion was measured in this study. It was shown that
50 μg/ml DEP could significantly increase levels of ROS
after 1 h stimulation (Figure 5A). To further examine
the effect of GSTM1 deficiency on DEP-induced ROS
production, we reduced intracellular GSTM1 levels using
lentiviral GSTM1 shRNA particles and then comparedFigure 5 GSTM1 knockdown enhances DEP-induced ROS
production. A, HBEC were treated with 50 μg/ml DEP for 1 h.
Intracellular ROS levels were measured using the fluorescent probe
carboxy-H2DCFDA and flow cytometry. B, HBEC were infected with
10 moi of lentiviral non-target (scrambled) or GSTM1 shRNA particles
for 24 h, respectively. Confluent cells were treated with 50 μg/ml
DEP for 4 h and ROS levels measured as described previously. *,
compared to PBS control (Ct), P< 0.05.
Figure 6 NAC reduced DEP-induced ERK and Akt
phosphorylation, and IL-8 and IL-1β expression. A and B, HBEC
were pretreated with 10 mM NAC for 2 h before further stimulation
with 50 μg/ml DEP for 1 h. Phosphorylated ERK and Akt was
measured using imunoblotting. C and D, HBEC were pretreated with
10 mM NAC for 2 h before further stimulation with 50 μg/ml DEP
for 24 h. Levels of IL-8 and IL-1β proteins were measured using
ELISA. *, compared to DEP, P< 0.05.
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sufficient or deficient GSTM1 after DEP treatment.
GSTM1 sufficient or deficiency cells were treated with
50 μg/ml DEP for 4 h and ROS levels measured. As
shown in Figure 5B, in the cells infected with control
shRNA DEP stimulation markedly increased ROS pro-
duction. In contrast, in the cells containing GSTM1
shRNA DEP-induced ROS production was further
increased, indicating that GSTM1 deficiency can increase
the production of intracellular ROS in DEP-treated
HBEC, possibly resulting in enhanced ERK and PI3K/
Akt activation.
Effect of the antioxidant NAC on intracellular ROS levels,
ERK and Akt phosphorylation, and IL-8 and IL-1β
expression
To further examine the involvement of ROS in DEP-
induced cellular responses as described previously, we
pretreated HBEC with N-acetyl-L-cysteine (NAC) prior
to DEP stimulation (50 μg/ml). The antioxidant NAC is
a thiol-reducing agent that can antagonize cellular ROS.
Levels of phosphorylated ERK and Akt, and IL-8 and IL-
1β protein were measured. As shown in Figure 6, pre-
treatment with NAC significantly inhibited DEP-induced
ERK and Akt phosphorylation, as well as IL-8 and IL-1β
expression. Taken together, these data suggested that
ROS played an important role in DEP-induced ERK and
Akt activation, and subsequent up-regulation of IL-8
and IL-1β. NAC is derivative of the amino acid cysteine
and can be proposed to boost levels of glutathione, the
substrate of GSTM1. Therefore, the fact that NAC sup-
plementation inhibited DEP-induced oxidative and pro-
inflammatory effect supported the role GSTM1 played
against airway inflammation.
Conclusion
This in vitro study using primary human bronchial epi-
thelial cells provides experimental evidence in support of
the notion that the GSTM1 null phenotype is a risk fac-
tor for DEP-induced airway inflammation. Specifically,
knockdown of GSTM1 leads to enhanced IL-8 and IL-1β
expression in primary human bronchial epithelial cells
exposed to DEP. Furthermore, this study demonstrates
that GSTM1 knockdown increases DEP-induced IL-8





cetate (carboxy-H2DCFDA) was purchased from Invitro-
gen Corporation (Carlsbad, CA). Deferoxamine (DFO)
mesylate was purchased from Sigma-Aldrich (St. Louis,
MO). N-acetyl-L-cysteine (NAC), U0126 and wortmanninwere obtained from EMD Chemicals (Gibbstown, NJ).
The rabbit antibodies against phospho-ERK and Akt,
and pan ERK and Akt were obtained from Cell Signal-
ing Technology (Beverly, MA). Horseradish peroxidase
(HRP)-conjugated goat anti-rabbit antibody was
obtained from Santa Cruz Biotechnology (Santa Cruz,
CA). IL-8 and IL-1β ELISA assay kits were purchased
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reagents were obtained from Thermo Scientific (Hunts-
ville, AL). MISSION lentiviral non-target shRNA and
GSTM1 shRNA transduction particles were purchased
from Sigma-Aldrich Corporation (St. Louis, MO).
Cell culture
Primary human bronchial epithelial cells (HBEC) were
obtained from healthy adult human volunteers by brush
biopsy of the mainstem bronchus using a cytology brush
during fiberoptic bronchoscopy, conducted under a
protocol approved by the Committee on the Protection
of the Rights of Human Subjects at the University of
North Carolina at Chapel Hill. HBEC were initially pla-
ted in supplemented bronchial epithelial cell basal
medium (0.5 ng/ml human epidermal growth factor,
0.5 μg/ml hydrocortisone, 5 μg/ml insulin, 10 μg/ml
transferrin, 0.5 μg/ml epinephrine, 6.5 ng/ml triiodothyr-
onine, 50 μg/ml gentamycin, 50 ng/ml amphotericin-B,
52 μg/ml bovine pituitary extract and 0.1 ng/ml retinoic
acid) on tissue culture flasks and expanded in the same
growth media.
DEP sample and preparation
The DEP used in this study was one (DEP5) of the seven
DEP samples generated at the US Environmental Protec-
tion Agency’s National Risk Management Research La-
boratory, Research Triangle Park, North Carolina, USA,
using a 30 kW (40 hp) 4-cylinder indirect injection
Deutz diesel engine (Model BF4M1008) under load of a
22.3 kW (30 hp) Saylor-Beall air compressor (Model
707). The exhaust was diluted with ambient air (3:1) to
near ambient temperatures (~35°C) and directed to a
small 4.2 m3/min (150 ft3/min) rated Dustex bag house
(Model T6-35-9) containing Nomex felt bags. The bags
were periodically reversed pulsed using compressed air
to remove the accumulated DEP which were collected
from the hopper at the end of each day and stored refri-
gerated (41°C) in glass sample jars for the in vitro assays
[35]. The percentage of extractable organic matter
(EOM) of DEP was about 31%. These particles contained
high concentrations of lower-molecular-weight polycyc-
lic aromatic hydrocarbon, phenanthrene, fluoranthene,
pyrene, and metals [34].
DEP stored in the glass sample jar, as described previ-
ously, were suspended in molecular grade water (Media-
tech Inc, Manassas, VA) to make a stock solution of
1 mg/ml, and sonicated just before incubated with
HBEC. The particle size was less than 0.45 μm.
Enzyme linked immunosorbent assay (ELISA)
After exposure of HBEC to DEP for 24 h, the culture
media were collected and centrifuged. Levels of IL-8 and
IL-1β proteins in the supernatants were measured withhuman IL-8 and IL-1β ELISA kits following the manu-
facturer's instructions.Immunoblotting
HBEC exposed to DEP were washed twice with ice-cold
phosphate-buffered saline (PBS), and then lysed in RIPA
buffer (1x PBS, 1% nonidet P-40, 0.5% sodium deoxycho-
late, 0.1% SDS, and protease inhibitors: 20 μg/ml leupeptin,
20 μg/ml aprotinin, 0.5 mM phenylmethylsulfonyl fluoride,
200 μM sodium orthovanadate, and 20 mM sodium fluor-
ide). The supernatants of cell lysates were subjected to
SDS-PAGE. Proteins were transferred onto nitrocellulose
membrane. Membrane was blocked with 5% nonfat milk,
washed briefly, incubated with primary antibody at 4°C
overnight, followed by incubating with corresponding
HRP-conjugated secondary antibody for 1 h at room
temperature. Immunoblot images were detected using
chemiluminescence reagents and the Fujifilm LAS-
3000 imaging system (Fuji Medical Systems, USA).GSTM1 knockdown assay
5 × 104 HBEC were placed in a 12 well plate and grown
overnight. 10 moi (multiplicity of infection) of lentiviral
non-target (scrambled) or GSTM1 shRNA particles in
0.5 ml bronchial epithelial growth medium were incu-
bated with HBEC for 24 h. The infection medium was
removed and replaced with fresh growth medium. Upon
confluence, HBEC were lysed and assayed for GSTM1
mRNA levels and GSTM1 protein, respectively.Real-time polymerase chain reaction
HBEC infected with lentiviral scrambled or GSTM1
shRNA particles were lysed with TRIZOL reagent (Invi-
trogen Corporation, Carlsbad, CA) and RNA extracted.
Total RNA (100 ng), 0.5 mM NTP (Pharmacia, Piscat-
away, NJ), 5 μM random hexaoligonucleotide primers
(Pharmacia, NJ), 10 U/μl RNase inhibitor (Promega,
CA), and 10 U/μl Moloney murine leukemia virus RT
(GIBCO-BRL Life Technologies) were incubated in a
40°C water bath for 1 h in 50 μl of 1x PCR buffer to
synthesize first-strand cDNAs. The reverse transcription
was inactivated by heating at 92°C for 5 min. Oligo-
nucleotide primer pairs and fluorescent probes for
GSTM1 and actin were obtained from Applied Biosys-
tem (Carlsbad, CA).
Quantitative fluorogenic amplification of cDNA was
performed using the ABI Prism 7500 Sequence Detection
System (Perkin-Elmer, CA). The relative abundance of
GSTM1 mRNA levels was calculated using the difference
between the cycle threshold (CT) of the GSTM1 mRNA
sequence and the reference actin mRNA sequence.
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(ROS)
The intracellular formation of ROS in HBEC was
detected using the fluorescent ROS probe carboxy-
H2DCFDA. Carboxy-H2DCFDA is a cell-permeant indi-
cator for ROS that is nonfluorescent until the acetate
groups are removed by intracellular esterases and oxida-
tion occurs within the cell [55]. The green fluorescence
produced by HBEC is proportional to the amount of
ROS produced. Briefly, confluent HBEC were pre-
incubated with 20 μM carboxy-H2DCFDA at 37°C for
1 h prior to exposure to 50 μg/ml DEPs. Cells were
detached by 0.05% trypsin-EDTA, washed once with
PBS, suspended in 0.5 ml PBS and put on ice before
determination of green fluorescence intensity. Flow
cytometry was performed with a FACSORT (Becton–
Dickinson, Miami, FL, USA) by using an argon-ion
laser (wavelength 488 nm). The FACSORT was cali-
brated with Calibrite beads before each use, and 6000
events were counted for all sample runs. Relative cell
size and density/granularity were quantified by analyz-
ing light-scatter properties using CellQuest software
(Becton–Dickinson), namely forward scatter for cell
size and side scatter for density/granularity, and record-
ing the mean fluorescence intensities for each.
Statistical analysis
Data are presented as means±SE. Data were evaluated
using nonparametric paired t tests with the overall α
level set at 0.05. One-way ANOVA was used to analyze
the dose-dependent trends of IL-8 and IL-1β protein
expression.
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